CANNABIS SCIENCE
Real-World Evidence: Cannabinoid Therapy in Patients on Incretin (GLP-1 RA) Weight Management Protoc
Oct 17, 2026
Real-World Evidence: Cannabinoid Therapy in Patients on Incretin (GLP-1 RA) Weight Management Protocols
Cannabinoids & Statins & Lipid-Lowering Agents: Evidence, Pharmacokinetics & Safety Review - Dr. Ben
Oct 17, 2026
Cannabinoids & Statins & Lipid-Lowering Agents: Evidence, Pharmacokinetics & Safety Review
Cannabinoid Hyperemesis Syndrome (CHS): Concentrates, Hot Water Relief & Absolute Cessation Criteria
Oct 17, 2026
Cannabinoid Hyperemesis Syndrome (CHS): Concentrates, Hot Water Relief & Absolute Cessation Criteria
Real-World Evidence: Sleep Latency, Nocturnal Awakenings & Minor Cannabinoids (CBN/CBG) across 24,00
Oct 16, 2026
Real-World Evidence: Sleep Latency, Nocturnal Awakenings & Minor Cannabinoids (CBN/CBG) across 24,000+ Visits
Cannabinoids & Antidepressants & SSRIs / SNRIs: Evidence, Pharmacokinetics & Safety Review - Dr. Ben
Oct 16, 2026
Cannabinoids & Antidepressants & SSRIs / SNRIs: Evidence, Pharmacokinetics & Safety Review
Pharmacy research setting representing CBD pharmacology
Oct 16, 2026
Low-Dose CBD and Therapeutic Value: What the New Clinical Pharmacology Review Found
Real-World Evidence: Pediatric Neurodevelopment & Behavioral Dysregulation in Physician-Co-Managed C
Oct 16, 2026
Real-World Evidence: Pediatric Neurodevelopment & Behavioral Dysregulation in Physician-Co-Managed Cohorts
Cannabinoids & Incretin Mimetics & GLP-1 Receptor Agonists: Evidence, Pharmacokinetics & Safety Revi
Oct 16, 2026
Cannabinoids & Incretin Mimetics & GLP-1 Receptor Agonists: Evidence, Pharmacokinetics & Safety Review
Physical therapy session, representing chronic pain research
Oct 16, 2026
Medical Cannabis for Chronic Pain: Function, Life Enjoyment, and Pain Scores
Clinical Pharmacology of Cannabinoids and Anticoagulant Interactions - Dr. Benjamin Caplan
Oct 15, 2026
Cannabinoids & Blood Thinners & Anticoagulants: Evidence, Pharmacokinetics & Safety Review
Real-World Evidence on Pain Interference and Opioid Sparing from CED Clinic Registry
Oct 15, 2026
Real-World Evidence: Longitudinal Pain Interference & Opioid Sparing across 32,000+ Clinical Encounters
Endocannabinoid system dysregulation in non-communicabl | CED Clinic | cannabis science digest
Oct 15, 2026
Endocannabinoid system dysregulation in non-communicable diseases: implications for skeletal muscle health.
Real-World Evidence: Cannabinoid Therapy in Patients on Incretin (GLP-1 RA) Weight Management Protoc
Oct 17, 2026
Real-World Evidence: Cannabinoid Therapy in Patients on Incretin (GLP-1 RA) Weight Management Protocols
Cannabinoids & Statins & Lipid-Lowering Agents: Evidence, Pharmacokinetics & Safety Review - Dr. Ben
Oct 17, 2026
Cannabinoids & Statins & Lipid-Lowering Agents: Evidence, Pharmacokinetics & Safety Review
Cannabinoid Hyperemesis Syndrome (CHS): Concentrates, Hot Water Relief & Absolute Cessation Criteria
Oct 17, 2026
Cannabinoid Hyperemesis Syndrome (CHS): Concentrates, Hot Water Relief & Absolute Cessation Criteria
Real-World Evidence: Sleep Latency, Nocturnal Awakenings & Minor Cannabinoids (CBN/CBG) across 24,00
Oct 16, 2026
Real-World Evidence: Sleep Latency, Nocturnal Awakenings & Minor Cannabinoids (CBN/CBG) across 24,000+ Visits
Cannabinoids & Antidepressants & SSRIs / SNRIs: Evidence, Pharmacokinetics & Safety Review - Dr. Ben
Oct 16, 2026
Cannabinoids & Antidepressants & SSRIs / SNRIs: Evidence, Pharmacokinetics & Safety Review
Pharmacy research setting representing CBD pharmacology
Oct 16, 2026
Low-Dose CBD and Therapeutic Value: What the New Clinical Pharmacology Review Found
Real-World Evidence: Pediatric Neurodevelopment & Behavioral Dysregulation in Physician-Co-Managed C
Oct 16, 2026
Real-World Evidence: Pediatric Neurodevelopment & Behavioral Dysregulation in Physician-Co-Managed Cohorts
Cannabinoids & Incretin Mimetics & GLP-1 Receptor Agonists: Evidence, Pharmacokinetics & Safety Revi
Oct 16, 2026
Cannabinoids & Incretin Mimetics & GLP-1 Receptor Agonists: Evidence, Pharmacokinetics & Safety Review
Physical therapy session, representing chronic pain research
Oct 16, 2026
Medical Cannabis for Chronic Pain: Function, Life Enjoyment, and Pain Scores
Clinical Pharmacology of Cannabinoids and Anticoagulant Interactions - Dr. Benjamin Caplan
Oct 15, 2026
Cannabinoids & Blood Thinners & Anticoagulants: Evidence, Pharmacokinetics & Safety Review
Real-World Evidence on Pain Interference and Opioid Sparing from CED Clinic Registry
Oct 15, 2026
Real-World Evidence: Longitudinal Pain Interference & Opioid Sparing across 32,000+ Clinical Encounters
Endocannabinoid system dysregulation in non-communicabl | CED Clinic | cannabis science digest
Oct 15, 2026
Endocannabinoid system dysregulation in non-communicable diseases: implications for skeletal muscle health.
CANNABIS NEWS
Editorial image for CBD Gummies to Lower Blood Sugar: What the Evidence Actually Shows
Oct 17, 2026
CBD Gummies to Lower Blood Sugar: What the Evidence Actually Shows
ced pexels 6942071
Oct 17, 2026
CBD Gummies for Autism Symptoms – Clinical Insights
cbd gummies for lung issues what the evidence sho 1
Oct 17, 2026
CBD Gummies for Lung Issues: What the Evidence Shows and How They Fit Into Daily Wellness
cbd gummies and psychosis what the evidence shows
Oct 16, 2026
CBD Gummies and Psychosis: What the Evidence Shows for Everyday Use
does cbd gummies make you sleepy what the evidenc 1
Oct 16, 2026
Does CBD Gummies Make You Sleepy? What the Evidence and Experience Actually Show
Clinical Research & Evidence Review: Week in Review: Clinical Breakthroughs in Metabolism, Cannabinoids, Primary Care, and AI (10/9 – 10/16/26)
Oct 16, 2026
Week in Review: Clinical Breakthroughs in Metabolism, Cannabinoids, Primary Care, and AI (10/9 – 10/16/26)
can cbd gummies cause psychosis pathologica
Oct 16, 2026
Can CBD Gummies Cause Psychosis? – Clinical Insights
Mabewo Phytopharm Targets Inflammatory Pain and Arthritis with Proprietary Cannabinoid Formulations — CED Clinic Patent Watch
Oct 16, 2026
Mabewo Phytopharm Targets Inflammatory Pain and Arthritis with Proprietary Cannabinoid Formulations
New Cannabis Cultivar 4D2 Secures Patent for Varin and Classical Cannabinoids — CED Clinic Patent Watch
Oct 16, 2026
New Cannabis Cultivar 4D2 Secures Patent for Varin and Classical Cannabinoids
The Endocannabinoid System Was Here All Along
Oct 16, 2026
The Endocannabinoid System Was Here All Along
cbd gummies for women sex what the evidence shows
Oct 16, 2026
CBD Gummies for Women Sex: What the Evidence Shows and How They Fit Into Daily Wellness
do cbd gummies work reddit real experiences rese
Oct 16, 2026
Do CBD Gummies Work Reddit: Real Experiences, Research, and What Actually Matters
Editorial image for CBD Gummies to Lower Blood Sugar: What the Evidence Actually Shows
Oct 17, 2026
CBD Gummies to Lower Blood Sugar: What the Evidence Actually Shows
ced pexels 6942071
Oct 17, 2026
CBD Gummies for Autism Symptoms – Clinical Insights
cbd gummies for lung issues what the evidence sho 1
Oct 17, 2026
CBD Gummies for Lung Issues: What the Evidence Shows and How They Fit Into Daily Wellness
cbd gummies and psychosis what the evidence shows
Oct 16, 2026
CBD Gummies and Psychosis: What the Evidence Shows for Everyday Use
does cbd gummies make you sleepy what the evidenc 1
Oct 16, 2026
Does CBD Gummies Make You Sleepy? What the Evidence and Experience Actually Show
Clinical Research & Evidence Review: Week in Review: Clinical Breakthroughs in Metabolism, Cannabinoids, Primary Care, and AI (10/9 – 10/16/26)
Oct 16, 2026
Week in Review: Clinical Breakthroughs in Metabolism, Cannabinoids, Primary Care, and AI (10/9 – 10/16/26)
can cbd gummies cause psychosis pathologica
Oct 16, 2026
Can CBD Gummies Cause Psychosis? – Clinical Insights
Mabewo Phytopharm Targets Inflammatory Pain and Arthritis with Proprietary Cannabinoid Formulations — CED Clinic Patent Watch
Oct 16, 2026
Mabewo Phytopharm Targets Inflammatory Pain and Arthritis with Proprietary Cannabinoid Formulations
New Cannabis Cultivar 4D2 Secures Patent for Varin and Classical Cannabinoids — CED Clinic Patent Watch
Oct 16, 2026
New Cannabis Cultivar 4D2 Secures Patent for Varin and Classical Cannabinoids
The Endocannabinoid System Was Here All Along
Oct 16, 2026
The Endocannabinoid System Was Here All Along
cbd gummies for women sex what the evidence shows
Oct 16, 2026
CBD Gummies for Women Sex: What the Evidence Shows and How They Fit Into Daily Wellness
do cbd gummies work reddit real experiences rese
Oct 16, 2026
Do CBD Gummies Work Reddit: Real Experiences, Research, and What Actually Matters
ced pexels 2950003
Cannabis News

CED News Digest: Misleading Labels on Delta-8 Products and More

Dr. Benjamin Caplan, MD
By Benjamin Caplan, MD
2 Min Read
Comments Off on CED News Digest: Misleading Labels on Delta-8 Products and More

CED News Digest, Above Threshold, 10 items

This digest groups recent cannabis news selected by the CED Merge Engine.

Study Highlights Misleading Labels on Delta-8 Products | Cannabis Sciences – Labroots

Original source

New lab alert raises questions about contaminant testing consistency #2

A state testing warning highlighted inconsistent contaminant screening and possible enforcement spillover.

Original source

Landmark study finds no evidence medical cannabis treats depression, anxiety or PTSD

Original source

Characterization of Cannabis Cultivars Using Public Testing Data – Labroots

Original source

Lancet Review of Medical Cannabis in Mental Health – What the Study Shows

Original source

Alabama Medical Cannabis Commission audit finds violations, $200K overpayment – WBRC

Original source

Minnesota cannabis officials recall Tidal Wave THC vapes for high THC content – KSTP

Original source

Audit finds Alabama Medical Cannabis Commission violated state law in five areas

Original source

State audit finds major issues with Alabama Medical Cannabis Commission

Original source

Audit Finds Noncompliance by Alabama Medical Cannabis Commission – Ganjapreneur

Original source






{“@context”: “https://schema.org”, “@type”: “CollectionPage”, “name”: “CED News Digest, Above Threshold, 10 items”, “about”: [“alabama medical cannabis commission audit finds”, “audit finds alabama medical cannabis commission”, “audit finds noncompliance alabama medical cannabis”, “characterization cannabis cultivars using public testing”, “lancet review medical cannabis mental health”, “landmark study finds no evidence medical”, “minnesota cannabis officials recall tidal wave”, “new lab alert raises questions about”, “state audit finds major issues alabama”, “study highlights misleading labels delta 8”]}


CED Clinic logo
Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.
Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

Dr. Benjamin Caplan

RELATED READING AT CED CLINIC
Continue exploring the evidence
Alabama Medical Cannabis Commission audit finds violations, $200K overpayment – WBRC

Detailed report on audit findings revealing violations and financial overpayments within the Alabama Medical Cannabis Commission.

Read the audit report

Landmark study finds no evidence medical cannabis treats depression, anxiety or PTSD

Comprehensive study evaluating the efficacy of medical cannabis in treating mental health disorders with no supporting evidence found.

Explore the study findings

Minnesota cannabis officials recall Tidal Wave THC vapes for high THC content – KSTP

Official recall of Tidal Wave THC vape products due to higher than labeled THC content, highlighting regulatory enforcement actions.

Learn about the recall

Read next

CBD Gummies to Lower Blood Sugar: What the Evidence Actually Shows

Tags:

Dr. Benjamin Caplan, MD
Author

Benjamin Caplan, MD

Benjamin Caplan, MD, is a board-certified Family Physician, author, researcher, and internationally recognized expert in cannabinoid medicine and the endocannabinoid system. Founder of CED Clinic and author of The Doctor-Approved Cannabis Handbook, he has spent more than two decades advancing evidence-based cannabis care, medical education, and clinical research. Dr. Caplan mentors the Harvard Business School Cannabis Club, and helped to launch the inaugural HBS Cannabis Business Conference, contributed to leading medical journals, advised healthcare and policy organizations, and built clinical and technology platforms designed to translate complex scientific evidence into practical care. His work sits at the intersection of medicine, research, technology, and health policy, with a focus on improving how patients, clinicians, and institutions understand and use cannabinoid-based therapies.

Follow Me
Other Articles
Copyright 2026 CED Clinic. All rights reserved.
Research Assistant
CED Clinic Research Assistant (beta)
Answers are generated by software, not written by Dr. Caplan
CED Clinic Research Assistant (beta) Answers are generated by software from published research. They are not written or reviewed by Dr. Caplan.
This is a beta system and its answers may contain errors. For any medical question, please consult a licensed clinician who knows you and your personal medical history.
This assistant explains what published studies say in general terms. It cannot advise on your dose, your medications or your treatment plan, and it will not use your name. Please do not include personal details.
Example questions:
CED Clinic Research Assistant (beta). Educational only. Not medical advice.
CED Clinic
CED Clinic Home
Explore
Cannabis Science
Research & Clinical
Cannabis News
Policy, Humor & News
Metabolic Health
GLP-1 Care & Science
Cannabis Recipes
Infused Foods & Drinks
Book an Appointment Contact CED Clinic
Recent Posts
Loading…
MENU